These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8025971)

  • 1. [The therapeutic strategy in benign liver tumors: a 20-year experience].
    Mangiante G; Nicoli N; Marchiori L; Procacci C; Giorgetti ; Colombari R; Aurola PP; Serio G
    Chir Ital; 1994; 46(1):50-60. PubMed ID: 8025971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Focal nodular hyperplasia and liver cell adenoma: operation or observation?].
    Ott R; Hohenberger W
    Zentralbl Chir; 1998; 123(2):145-53. PubMed ID: 9556887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatocellular adenoma and focal nodular hyperplasia].
    Mangiante G; Pistacchi E; Marchiori L; Nicoli N; Dagradi A
    Chir Ital; 1989; 41(2-3):117-28. PubMed ID: 2561631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome.
    Reddy KR; Kligerman S; Levi J; Livingstone A; Molina E; Franceschi D; Badalamenti S; Jeffers L; Tzakis A; Schiff ER
    Am Surg; 2001 Feb; 67(2):173-8. PubMed ID: 11243545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia.
    Closset J; Veys I; Peny MO; Braude P; Van Gansbeke D; Lambilliotte JP; Gelin M
    Hepatogastroenterology; 2000; 47(35):1382-4. PubMed ID: 11100357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and surgical therapy of benign liver tumors].
    Pertschy J; Rückert JC; Manger T
    Zentralbl Chir; 1994; 119(7):495-500. PubMed ID: 7941797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benign liver tumors].
    Cherqui D
    J Chir (Paris); 2001 Feb; 138(1):19-26. PubMed ID: 11240457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic and therapeutic strategies in hepatocellular adenoma].
    Weimann A; Fronhoff K; Gratz KF; Maschek H; Bartels M; Klempnauer J; Ringe B; Pichlmayr R
    Zentralbl Chir; 1998; 123(2):140-4. PubMed ID: 9556886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicology and Carcinogenesis Studies of Furan (CAS No. 110-00-9) in F344 Rats and B6C3F1 Mice(Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Jan; 402():1-286. PubMed ID: 12621516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential diagnosis and therapy of benign liver tumors].
    Jonas S; Vogl TJ; Schwarz W; Neuhaus P
    Ther Umsch; 1998 Feb; 55(2):120-6. PubMed ID: 9545855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign liver tumors: differential diagnosis and indications for surgery.
    Weimann A; Ringe B; Klempnauer J; Lamesch P; Gratz KF; Prokop M; Maschek H; Tusch G; Pichlmayr R
    World J Surg; 1997; 21(9):983-90; discussion 990-1. PubMed ID: 9361515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
    Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
    Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgery of benign liver tumors: indications for treatment. Personal experience and review of the literature].
    Petri A; Höhn J; Wolfárd A; László Kókai E; Kocsis Savanya G; Boros M; Balogh A
    Magy Onkol; 2003; 47(4):391-5. PubMed ID: 14716436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of benign liver tumours--indications and results].
    Skalický T; Treska V; Sutnar A; Liska V; Molácek J; Mírka H; Ferda J; Ohlídalová K; Slauf F; Novák M
    Zentralbl Chir; 2009 Apr; 134(2):141-4. PubMed ID: 19382044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery of benign liver tumors: indications for treatment: twenty years' experience.
    Petri A; Höhn J; Kókai EL; Savanya GK; Lázár G
    Hepatogastroenterology; 2008; 55(82-83):592-5. PubMed ID: 18613414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.